Related Experiment Videos
Mannosidosis. New clinical presentation, enzyme studied, and carbohydrate analysis
Archives of Neurology
|January 1, 1977
Summary
Mannosidosis, a rare metabolic disorder, involves alpha-mannosidase enzyme deficiency causing mannose buildup. Early screening in individuals with intellectual disability and gum hyperplasia is recommended.
Area of Science:
- Biochemistry
- Genetics
- Metabolic Disorders
Background:
- Mannosidosis is a rare lysosomal storage disease caused by alpha-mannosidase deficiency.
- This deficiency leads to the accumulation of mannose-rich complex carbohydrates in tissues.
- It is an inherited metabolic disorder affecting multiple organ systems.
Observation:
- Two unrelated males, aged 6 and 26, with nonprogressive encephalopathy and moderate intellectual disability were studied.
- The older patient presented with unique massive gingival hyperplasia, a feature not commonly associated with mannosidosis.
- Histiocytes in the hyperplastic gums contained glycoprotein material, suggesting widespread storage.
Findings:
- The ratio of mannose to other urinary carbohydrates effectively determined mannose storage.
- Alpha-mannosidase deficiency was most reliably detected at pH values below 4.0.
- Zinc demonstrated in vitro activation of the mutant enzyme, indicating potential therapeutic avenues.
Implications:
- Early identification of mannosidosis is crucial for management and intervention.
- Screening individuals with intellectual disability and Hurler-like features, particularly with gum hyperplasia, is advised.
- The findings suggest a potential therapeutic strategy involving zinc supplementation for mannosidosis.